What happens when half-priced Ozempic suddenly disappears faster than a donut at a diet
convention? The FDA just pulled the plug on compounded GLP-1 drugs, leaving millions scrambling
to choose between $1,300/month prescriptions and back-alley “discounts” riskier than a gas station
sushi platter. Dive into the chaos: patients like Michelle facing spine surgery relapses, Big Pharma’s
legal smackdowns, and why docs compare off-brand meds to “pancreas malware.” But don’t panic
yet—we’ve got your survival playbook, plus a wildcard solution involving beer’s bitter cousin. Stick
around to discover how Calocurb—a hop-based supplement—might outsmart hunger hormones
without needles or shady pharmacies. Your next craving killer could grow in a field, not a lab.
Special Guest: Sarah Kennedy – CEO of Calocurb, a natural GLP-1 activator